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Prognostic importance of vascular lesions in acute renal failure
with microangiopathic hemolytic anemia (hemolytic-uremic syn-
drome): Clinicopathologic study in adults. Renal biopsies ob-
tained from 20 adult patients within 30 days after onset of acute
renal failure with microangiopathic hemolytic anemia ("the he-
molytic-uremic syndrome") were studied. Lesions were graded
independently by two observers without knowledge of the clini-
cal history. All patients who did not have refractory hyper-
tension were treated with heparin. Ten of the patients died, and
four developed end-stage renal failure requiring chronic dialysis.
Six patients, however, had a relatively good outcome: two re-
covered completely and four developed mild-to-moderate chron-
ic renal failure not requiring dialysis. The six patients with a good
Outcome had significantly less severe arterial intimal thickening
on biopsy compared with the remaining patients with a poor Out-
come. The patients with a good Outcome and those with a poor
Outcome did not differ in the severity of glomerular lesions. The
clinical features did not allow a prediction of late outcome. These
results suggest that early renal biopsies may be helpful in predict-
ing prognosis in the 'hemolytic-uremic syndrome." This clinical
syndrome may occur either in apparently healthy people, or may
complicate the course of a chronic essential hypertension.
Importance pronostique des lesions vasculaires au cours de
I'insutlisance renale aiguë avec anémie hemolytique micro-
angiopathique (syndrome hémolytique et urémique): Etude clini-
copathologique chez 20 adultes. Des biopsies rénales faites a des
malades adultes dans les 30 premiers jours d'unc insuffisance ré-
nale aiguë avec anemic hemolytique microangiopathique (Ic syn-
drome hémolytique et urémique) ant ëté étudiées. Les lesions
ont etC chiffrCes independamment par deux observateurs
ignorant l'histoire cliniquc. Tous les malades indemnes d'hy-
pertension rCfractaire ont etC traitCs par l'hCparine. Dix de
ces malades sont marts et quatre ont développe une insuffisance
rénale terminale qui a impose Ic recours a l'hemodialyse. Six
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malades, cependant, ont eu une evolution favorable: deux ont
complétement guCri et quatre ont atteint un stade d'insuffisance
rénale chronique de moyenne intensitC n'imposant pas
l'hCmodialyse. Les six malades dont l'Cvolution a etC favorable
avaient a Ia biopsie des lesions d'Cpaississement artCriel intimal
significativement mains sévêres que celles des autres malades
dont l'Cvolution a etC plus grave. Les lesions glomérulaires
n'étaient pas de gravité différente dans ces deux categories de
malades. Les éléments cliniques n'ont pas permis de prevenir
l'Cvolution ultérieure. Ces rCsultats suggèrent que les biopsies
rénales peuvent Ctre utiles dans l'établissement du pronostic de
syndrome hémolytique et urémique. Ce syndrome peut survenir
chez des sujets en apparente bonne sante ou peut compliquer
I'Cvolution dune hypertension essentielle chronique.
The hemolytic uremic syndrome (HUS), which is
characterized by acute renal failure and micro-
angiopathic hemolytic anemia, often with thrombo-
cytopenia, is well known in infancy and childhood
and represents one of the major causes of acute re-
nal failure in this age group [1, 2]. An extensive and
confusing literature has recently been produced de-
scribing a similar syndrome in adults. Some cases
have been described in association with pregnancy,
whereas others have occurred in women taking oral
contraceptives [3—10]. Clinical and morphologic fea-
tures identical with HUS have been described in
scieroderma and in malignant essential hyper-
tension [11-13]. Because hypertension is common
in adults and is a frequent finding in the hemolytic-
uremic syndrome, it is often difficult to distinguish
between "pure" cases of HUS in adults and a simi-
lar syndrome occurring during malignant hyper-
tension."
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It has been unclear whether there are clearcut
morphologic differences between the various types
of HUS in adults, and whether renal biopsies can be
used to predict prognosis in this clinical syndrome.
There is apparently considerable overlap between
primary HUS and those occurring in association
with underlying hypertensive disease. We have not
therefore tried to separate the patients with primary
HUS from those with associated hypertensive dis-
eases.
Over a period of 9 years, we have observed a to-
tal of 35 adult patients with clinical and histologic
features compatible with HUS. The aim of the pres-
ent study was to analyze the clinical and histologic
features in the 20 patients (whether or not they were
hypertensive) that had a percutaneous renal biopsy
performed within the first month after onset of renal
failure and hemolytic anemia to see whether mor-
phologic features could be correlated with clinical
outcome. We have deliberately excluded late histo-
logic examinations as they could not bring any prog-
nostic information, most glomeruli being obsoles-
cent and the other renal lesions being too sclerotic
to be potentially reversible.
Methods
Twenty adult patients1 were included in the pres-
ent study. They were admitted to the renal intensive
care unit of Hôpital Tenon between 1969 and 1977
and represent about 2% of the total number of pa-
tients admitted for acute renal failure during the
same period. Other patients, including four with
multiple systemic sclerosis, presented also with
HUS, but they had only a late histologic examina-
tion (nephrectomy or postmortem), which therefore
did not bear prognostic significance. These patients
included 9 males and 11 females. The ages varied
from 21 to 62 years with a median of 36 years.
Clinically, all patients presented with acute renal
failure and hemolytic anemia. Acute renal failure
was defined as a rapid rise in blood urea and creati-
nine accompanied by oliguria (urine output less
than 500 mi/day) in the absence of reduced kidney
size. The presumptive diagnosis of hemolytic
anemia was made when a rapid drop in hematocrit
below 30% occurred in the absence of bleeding and
was associated with a reticulocytosis greater than
5%. Diagnosis was further strengthened by the find-
ing of a low serum haptoglobin level in all patients
(13/13) in whom it was measured. Fragmented red
cells were present in the blood smears of a majority
of patients in whom they were looked for, that is, in
9 of 14 patients. So these patients had a definite mi-
croangiopathic anemia.
As stated in the introduction, histologic material
was available on 35 patients. After review of this
material, however, it was clear that autopsy and ne-
phrectomy specimens contributed a biased sample
and that renal biopsies performed later than 1
month after onset of renal failure contributed little
to decisions about patient management. Thus, we
decided to concentrate on the 20 patients that had
renal biopsies performed up to 30 days after the on-
set of renal failure. Renal biopsies were only per-
formed when the platelet count was equal to or
greater than 100,000/mm3 and the diastolic blood
pressure was less than 100 mm Hg (on treatment).
All biopsy specimens were studied by light mi-
croscopy. They were fixed in Dubosq-Brasil fluid
and stained according to methods previously de-
scribed [14]. Immunofluorescent studies were car-
ried out on fresh-frozen tissue in 14 patients using
sera directed against IgG, IgA, 1gM, C3, and fibrino-
gen-related antigens [14].
The histologic sections were reviewed independ-
ently without knowledge of the clinical history by
two of us and were scored on a scale of 0 to 3 + for
the following changes: Glomerular lesions —Scle-
rosis, reduction in capillary lumens, mesangial fi-
brillarity, capillary loop thickening (Fig. 1), gb-
merular thrombosis (Fig. 2), glomerular necrosis,
cellular proliferation, congestion, and segmental so-
lidification (Fig. 3). Arterial lesions—Medial thick-
ening, intimal thickening, thrombi, necrosis, intimal
lipid, and reduplication of the inner elastic lamina.
Arteriolar lesions—Thrombosis, necrosis, hyper-
plastic thickening (Fig. 4), and reduction in luminal
diameter. Interstitium —Chronic inflammation,
acute inflammation, and fibrosis. Medullary ves-
sels —Accumulation of leukocytes in the vasa recta
(Fig. 5). Tubules—Necrosis, casts, and atrophy.
The scores assigned by the two observers were
averaged to arrive at the final scores assigned to
each case. Differences between groups were as-
sessed using the Wilcoxon two-sample test for non-
parametric data [15]. Some of the lesions assessed
are illustrated in Figs. 1 to 5.
1Five of these patients have been the subject of recent papers
dealing with HUS in pregnancy (Br Med J 2:479, 1975) and per-
sistent complement activity after nephrectomy (Gun Nephrol
6:437, 1976).
Results
Clinical findings. Seventeen of the patients had
hypertension at onset of HUS. In 16 of the patients
550 Morel-Maroger et al
Fig. 1. Capillary wall thickening. See reduplication of glomerular capillary walls with reduction
in lumina. Wilder's silver stain. x800
Fig. 2. Thrombosis, occlusion of lumina by erythrocytes and clear subendothelial spaces.
Masson's trichromic stain. x200
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Fig. 3. Solidification and ischemic changes in glomerular tufts, with one crescent in a glomeru-
lus, showing extensive tubular loss and interstitial fibroedema. Masson's trichromic stain.
x 80
Fig. 4. Disappearance of an arteriolar lumen due to cellular proliferation. Wilder's silver stain.
x 320
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Fig. 5. Accumulation of leukocytes in the vasa recta. Hematoxylin-eosin. x320
there were striking ocular abnormalities, including
soft exudates, papilloedema, and inflammatory reti-
neal detachment (see Table I). Thirteen patients
had acute pulmonary edema, purpura was present
in only four patients, generalized seizures occurred
in two patients (one with eclampsia), another pa-
tient developed hemiplegia. No peripheral neuropa-
thy was observed. In most patients the hemolytic
anemia was accompanied by abnormalities of blood
coagulation, that is, thrombocytopenia and raised
serum fibrinogen-fibrin degradation products
(FDP). Of the 20 patients, 13 had thrombocytopenia
(platelet count < 120,000/mm3) at the time of onset
of the disease. Raised FDP (that is, serum fibrin-
ogen related antigen > 8 .tg/m1 by latex agglutina-
tion test, or found by Ouchterlony's method) were
present in almost all patients (19/20) on admission.
Other blood-clotting tests were normal. None of the
patients fulfilled the criteria of acute disseminated
intravascular coagulation (DIC). Nevertheless, the
association of a thrombocytopenia with raised FDP
levels is consistent with a chronic DIC [15].
Associated conditions. Five patients had a his-
tory of chronic, well-tolerated hypertension for 4
months to 19 years prior to the onset of HUS. In
four patients, the HUS appeared to be related to
pregnancy. Two of these patients had severe tox-
emia and had the onset of HUS in the immediate
postpartum period (patient 1) or at the end of the
second trimester of pregnancy (patient 18). In the
other two patients (patients 12 and 5), HUS oc-
curred 2 weeks and 4 months after delivery. In
these two patients, one of whom was on oral con-
traceptives, pregnancy and the immediate post-
partum period had been entirely normal. In one ad-
ditional patient (patient 7), HUS occurred 8 months
after a normal pregnancy and delivery. HUS oc-
curred in two patients who had been taking oral
contraceptives for I month and 30 months, respec-
tively (patients 5 and 9). Patient 9 had acute myelo-
cytic leukemia in complete remission at the time of
onset of HUS. One additional patient (patient 14)
had received depot estrogen shots for 14 years. In
several patients, the onset of HUS was preceded by
fever or pharyngitis. Finally, in five patients (four
males and one female) there was no apparent an-
tecedent.
Immediate and long-term outcome. In eight pa-
tients death occurred in the acute phase of the dis-
ease from a few days to 3 months after the onset of
HUS. The causes of death are shown in Table 2. In
two patients, death was due to involvement of the
central nervous system, in two others it was related
to gastrointestinal hemorrhage. One patient (patient
19) had initial partial recovery but then died 1 year
later with severe hypertension and cerebral hemor-
rhage. In six patients oligoanuria persisted, and
they were placed on chronic hemodialysis (see
4
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Table 1. Clinical flndingsa
Interval Frag-
onset mented Low
Pa- Initial RB red hapto- Platelets
tient Sex Age BP Ocular fundus days cells globin FDP at onset Extrarenal signs
1 F 25 180/110 Normal 4 + + + 50,000 Convulsions, pulmonary edema
2 M 48 150/ 90 Grade 3, soft exudates 4 — ND + 110,000 Pulmonary edema
3 F 24 270/160 Grade 3, soft exudates 4 ? ND + 250,000 None
4 M 52 250/120 Grade 3, soft exudates 5 + ND + 60,000 Purpura, hemiplegia, pulmonary
edema
5 F 23 140/ 70 Normal 5 + + + 70,000 Localized purpura
6 M 59 220/130 Grade 3, soft exudates 6 ? ND + 130,000 Pulmonary edema
7 F 25 120/ 80 Inflammatory retineal detachment 7 7 + + 140,000 Sudden blindness
8 F 36 270/110 Grade 4, soft exudates 8 + + + 90,000 None
9 F 30 130/ 80 Normal 8 + + + 100,000 None
10 F 43 170/110 Grade4 10 + + + 360,000 None
11 M 38 220/110 Grade 4, soft exudates 10 + + + 90,000 None
12 F 26 150/ 90 Normal 13 + + + 100,000 Pulmonary edema
13 M 33 210/160 Grade 4, soft exudates 15 — + — 420,000 None
14 F 62 190/ 60 Grade 4, soft exudates 20 + + + 40,000 Convulsions, Coombs +
cryoglobulinemia
15 M 37 240/160 Grade 3 21 7 + + 110,000 Pulmonary edema
16 F 38 170/110 Grade 3, soft exudates 30 — ND + 175,000 Coombs + purpura, low C3
17 M 21 190/110 Softexudates 30 + + + 90,000 Purpura,jaundice, convulsions
18 F 23 180/110 Normal 30 — + + 60,000 Cerebrovascular accident,
purpura
19 M 56 250/110 Grade 3 30 — ND + 40,000 Pulmonary edema
20 M 36 280/190 Grade 3 30 7 + + 80,000 Sudden blindness
Abbrevjations are defined as BP, blood pressure; ND, not done; FDP, fibrinogen-fibrin degradation products.
Table 2). Four patients received kidney transplants,
among whom three are living with a good transplant
function and one died.
In six patients, outcome was favorable (see Table
2). At the time of onset, blood pressure was normal
in only three of them but high in the three others. In
these patients, recovery of urinary output occurred
at 4, 6, 10, 23, 30, and 45 days. In two patients, in
whom HUS was related to pregnancy, a complete
clinical recovery rapidly occurred. (In one of these
resolution of renal histologic findings was docu-
mented by a second renal biopsy). The other four
patients developed chronic renal failure not requir-
ing dialysis. Three of these patients have continuing
hypertension.
Biopsy complications. In four patients, renal
biopsy was complicated by retroperitoneal hemato-
ma. In two of these patients, nephrectomy was per-
formed (one was severely hypertensive and had
both kidneys removed). In one patient the hemato-
ma was surgically removed, and in one patient it
spontaneously resolved.
Histologic features. We were not able to detect
morphologic differences between cases with dif-
ferent types of antecedents. Some significant dif-
ferences, however, were observed between biopsy
specimens from patients who subsequently recov-
ered or have mild chronic renal failure and biopsy
specimens from patients who subsequently died or
were placed on hemodialysis (Table 3). There was
no difference in the overall severity of the glomeru-
lar changes in the two groups; the sum of the as-
sessed glomerular lesions was nearly identical in the
two groups. In contrast, the degree of arterial in-
timal thickening was strikingly less in the group
with the good prognosis (P < 0.05, two-tailed test).
With a one-tailed test of significance (which as-
sumes that lesions could not have been more severe
in the group with a good outcome but could only be
equal or less severe), overall severity of the vascu-
lar lesions (sum of the assessed vascular lesions)
was significantly less severe in the group with good
outcome (P < 0.05) [16]. This difference was not
significant with the more conventional two-tailed
test (P < 0. 10). It appears that the difference in
overall severity of vascular lesions was not due to
vascular changes usually associated with age and
benign essential hypertension, such as medial hy-
pertrophy and elastic reduplication, but rather was
due to changes suggestive of intravascular coagu-
lation such as thrombosis, necrosis, and narrowing
of arteriolar lumen related to intimal proliferation of
hyalinosis. Four of the six patients in the group with
a favorable prognosis had less severe vascular le-
sions than any of the other patients in this study
(Table 2). The other two patients had moderately
554 Morel-Maroger et a!
Table 2. Histology and outcomea
10 7.25 17 0
11 6.75 11 1
12 9.25 1 0
13 7 7 0
14 8.5 12.75 1.75
+ + No renal recovery
+ Renal recovery after
I month
— + Recovery after 2 months
0 ND ND Partial recovery
0 ND ND Bilateral nephrectomy
1 ND ND Recovery
0 ND ND Recovery
— Chronicdialysis
— No recovery
Death: GI bleeding
Death: cerebral
hemorrhage
Transplanted, death:
sepsis
Death: thrombosis in left
atrium
Partial recovery chronic
hypertension
I kidney removed, death
(acute pancreatitis)
Mild chronic renal failure
Transplantation, death:
ulcerative colitis
Mild chronic renal failure
Total recovery
Chronic dialysis
Chronic dialysis
+ Delivery 4 months before
contraceptive pills I
month
+ None
+ Normal pregnancy 9 months
before
+ Hypertensive for 4 months,
acute sore throat
+ Acute leukemia 2 yr before,
contraceptive pills 2/z yr
+ 4 months of hypertension
+ Hypertension 5 yr, poorly
controlled, fever,
myalgias, arthralgias
+ Caesarean section 13 days
previously
— None
— Hypertensive 10 yr estrogen
implant posthysterectomy
antibodies to
estrogens
15 7.75 12 0 0 — Fib No recovery Death: cerebral accident — Hypertensive for 19 yr
Fib Recovery with recurrence
ND Bilateral nephrectomy
ND Bilateral nephrectomy
Fib Partial recovery
Bilateral nephrectomy
Hypertension + mild
chronic renal failure
Functioning transplant
Functioning transplant
After 1 year death: cerebral
hemorrhage
Death: pulmonary
embolism
+ Acute sore throat
— Fever, epilepsia of unknown
origin
+ Pregnancy 51/2 months
+ None
— 1 yr previously reversible
blindness
a Abbreviations are defined as ND, not done; GI, glomeruli; Art., arteries; TN, tubular necrosis; V,
fibrinogen; *, medulla not available; xx, no large arteries.
vessels; VR, vasa recta; Fib.,
severe vascular changes but also had accumulations
of leukocytes in the vasa recta, a change suggestive
of so-called "acute tubular necrosis" [12] which
was not observed in any of the other cases of HUS.
Positive fluorescence was observed in 10 of the 14
biopsy specimens in which immunofluorescent
studies were carried out. The most common stain-
ing pattern was the presence of fibrinogen in vessels
and in glomerular capillary loops (Fig. 6), some-
times accompanied by C3 (Fig. 7). In contrast to the
studies by Bohle et al [13], we did not observe sig-
nificant deposits of immunoglobulins in the glomer-
uli.
Discussion
In this study and in other published works on
HUS in adults, there are no definite clinical features
that allow a prediction of prognosis. The mortality
rate for HUS is high, as it is for acute renal failure in
general [17]. The overall mortality of 50% in the
present series is significantly higher than are the 13%
mortality (seven deaths out of 57 patients) observed
in proven cases of "acute tubular necrosis" biop-
sied during the same period at Hôpital Tenon [18]
and the 16% mortality observed by Gianantonio et
al in HUS in children [19], but it is not significantly
different from the overall mortality in patients with
Pa-
tient Histology
iF
.
Hepann
no. Gl. V TN VR GI. Art. Immediate outcome Late prognosis therapy Antecedent
1 3 0.75 0.75 * Fib —. Recovery Recovery +
2 1.75 5.75 0 ' — — No recovery, dialysis
3 6.50 14 0 * — + No recovery, bilateral
nephrectomy
4 3 10.5 0 0 Rapid death, cerebral
hemorrhage
5 9.5 ? xx 0 0 ND ND Bilateral nephrectomy
6 12.75
79
8 4.25
9 7.25
Eclampsia, child birth
(twins)
— Hypertension for 5 yr
+ None
— None
0
0
0
10.75 0
3.50 0.25
13.75 0
3.75 0
0
* Fib
C3
16 10.5 17.5 0 0.5 Fib
C3
17 9 11 0 0 ND
18 8.25 6.50 0 * ND
19 6.25 6.50 0 * Fib
C3
20 8 13 0.5 *
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Table 3. Comparison of histologic data in the two groups of
patients
Recovery or
CRF without Death or
dialysis dialysis(N=6) (N=14)
Sclerotic glomeruli 0.33 0.89
Reduction in capillary
lumina 1.71 1.63
Mesangial fibrillarity 1.38 1.04
Capillary loop thickening 1.83 2.02
Glornerular thrombi 0.38 0.45
Glomerular necrosis 0.17 0.04
Glomerular proliferation 0.08 0.07
Congestion 1.08 0.39
Segmental solidification 0.33 0.63
Total glomerular lesions 7.29 7.16
Arterial thickening media 0.08 0.14
Arterial thickening intima 1.25 (P < 0.05) 2.25
Arterial thrombi 0.0 0.54
Arterial necrosis 0.08 0.65
Arterial fatty changes 0.41 0.86
Elastic reduplication 1.25 1.34
Arteriolar thrombosis 0.38 0.82
Artenolar necrosis 0.58 0.50
Arteriolar proliferation 0.96 1.73
Artenolar reduction in
lumina 0.42 2.11
Total vascular lesions 5.41 (P < 0.10) 10.94
Interstitial lymphocytes 0.71 1.14
Interstitial polyps 0.17 0.11
Vasa recta lesion 0.25 (2/6 cases) 0.0(0/10 cases)
Fibrosis 1.25 1.78
Tubular necrosis 0.33 0.16
casts 1.08 1.46
atrophy 1.33 1.75
Mean age,yr 27 39
Number previously
hypertensive 1/6 4/14
Mean duration renal
failure,days 12.3 15.4
acute renal failure hospitalized at Hôpital Tenon
during the same period (37%).
Renal biopsy does allow a prediction of prognosis
in HUS. The question of the clinical value of renal
biopsy in this syndrome can be looked at in two
different ways. First, since in some cases HUS
may be difficult to diagnose on clinical grounds, the
question may be asked, 'Is renal biopsy of value in
atypical renal failure, that is, is biopsy useful in
acute renal failure difficult to categorize because of
insidious onset, absence of predisposing factors,
presence of hematuria or proteinuria, or other con-
fusing clinical features? To this question one can
answer unequivocal "yes." Previous studies from
this laboratory [18, 20-25] have shown that in this
clinical setting, renal biopsy has a low compli-
cation rate and may reveal a host of different gb-
merular, interstitial, vascular, or tubular disorders,
each of which has a different pathogenesis, progno-
sis, and (frequently) therapy. Second, one may ask,
"Is renal biopsy of value in clinically unequivocal
HUS?" Here the answer is more complex. Patients
with HUS have a higher incidence of postbiopsy
complications than do patients with other non-
vascular types of acute renal failure [3, 25-27] prob-
ably because of the accompanying hypertension. In
the present series, four patients had significant
bleeding after biopsy. Therefore, if renal biopsy is
not being used to help plan therapy but only to es-
tablish prognosis, it is probably not warranted in
clinically unequivocal HUS. For this reason, we do
not recommend late biopsy because the vascular
and glomerular lesions appear irreversible and do
not warrant any potentially dangerous therapy such
as anticoagulation.
Biopsy is warranted if it is being used to help
make therapeutic decisions, and here the usefulness
of heparin in HUS must be discussed. Several
groups have suggested that heparin therapy is bene-
ficial in patients with HUS and related syndromes
[27—31]. We have treated all our patients with hepa-
rin unless they had refractory hypertension. In the
future we will be more vigorous in our heparin ther-
apy in those patients with less severe vascular le-
sions, since we now know that they have better
prospects for recovery of renal function. Unfortu-
nately, there are no controlled trials on the use of
heparin in HUS in adults, and thus its use is des-
tined to remain controversial. The only controlled
trial of heparin in children with HUS was not able to
demonstrate a beneficial effect [321.
To our knowledge, ours is the first study of HUS
in adults to show that prognosis could be predicted
from histologic findings. Bohie et al [13] described
an "abortive" type of HUS ("primary malignant
nephrosclerosis"), which was characterized by
a paucity of vascular changes and occurred pre-
dominantly in children. He could demonstrate,
however, no significant differences in prognosis be-
tween this type of HUS and the more ordinary type
of HUS with severe vascular changes. In a study of
familial hemolytic uremic syndrome, Kaplan,
Chesney, and Drummond [33] found that siblings
who had nearly simultaneous onsets of HUS had a
relatively good prognosis, whereas siblings with on-
sets of disease more than a year apart had a poorer
prognosis. No histologic data, however, was pro-
vided in this study. In an extensive study of HUS in
children, Habib, Mathieu, and Royer [34] could find
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Fig. 6. Deposits offibrinogen-related antigens along the capillary walls and in the lumina of a glomerulus. Serum antifibrinogen. x200
Fig. 7. Coarse nodular deposis of C3 in a glomerulus. Serum anti-C3. ><200
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no morphologic differences between the curable
and the lethal forms.
In their original article on microangiopathic hemo-
lytic anemia, Brain, Dacie, and Hourihane [351 ex-
pressed the opinion that the hemolysis was the con-
sequence of direct contact between red cells and
diseased blood vessels. Most recent publications
suggest that intravascular coagulation is the prin-
ciple pathogenetic mechanism in HUS. Vassalli, Si-
mon, and Rouiller [36] have shown that many of the
ultrastructural features of HUS can be reproduced
in animals by producing low intravascular coagu-
lation. Our data are consistent with such an hypothe-
sis. It seems reasonable that occlusion of larger ves-
sels should have greater functional consequences
than occlusion of capillaries, and therefore it is not
surprising that arterial lesions are of greater prog-
nostic importance than glomerular lesions are in
HUS. Another point is that patients with HUS are
not immune from other more common types of
acute renal failure which may be superimposed on
HUS. Two of our patients (patients 1 and 16) thus
may represent a combination of HUS and "acute
tubular necrosis."
In conclusion, this work shows that HUS in
adults, different from what is known in children, is
the consequence of several underlying mechanisms.
In some instances, both glomerular lesions and evo-
lution are identical to the childhood syndrome. On
the other hand, patients who suffer from chronic ar-
terial lesions may develop HUS, perhaps in rela-
tion to a transient intravascular coagulation. Clini-
cally, the disorders are undistinguishable. Indeed,
hypertension may not be present at onset and devel-
op rapidly after the acute episode of HUS (see pa-
tients 5, 7, 9). Funduscopic anomalies in relation to
the vascular status may also occur in the absence of
a raised blood pressure (patient 7). For these rea-
sons, it seemsjustified to define the patients on a
morphologic basis if a renal biopsy can be per-
formed early, because the overall prognosis and the
therapeutic attitude will entirely result from the ren-
al biopsy findings.
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